Renata (DHA:RENATA) Short Interest


DHA:RENATA Renata PLC DHA:RENATA
83 GF Score
Price BDT446.30
GF Value BDT806.73
Valuation Significantly Undervalued
! 7 Warning Signs
View Full Analysis

What is Renata Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

DHA:RENATA vs ZTS, UTHR, VTRS: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Renata's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Renata Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Renata's Short Interest distribution charts can be found below:

* The bar in red indicates where Renata's Short Interest falls into.


DHA:RENATA
83GF Score
Renata PLC DHA:RENATA
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Renata (DHA:RENATA) Overvalued in 2026?

Based on GuruFocus' analysis, Renata stock appears to be undervalued. The current stock price of BDT446.30 is trading 44.7% below its estimated GF Value™ of BDT806.73. GuruFocus considers Renata to be Significantly Undervalued.

Key valuation signals for DHA:RENATA:

  • Short Interest:
  • GF Value™: BDT806.73 vs. price of BDT446.30 (44.7% below fair value)
  • GF Score™: 83/100 with 7 warning signs

No single metric tells the full story. See the DHA:RENATA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Renata Business Description

Address Plot Number 1, Milk Vita Road, Section-7, GPO Box No. 303, Mirpur, Dhaka, BGD, 1216
Renata PLC is a Bangladesh based pharmaceutical company. It is engaged in the manufacturing, marketing, and distribution of Human Pharmaceuticals, Animal Health Medicines, Nutritionals, and Vaccines. It manufactures various pharmaceutical products including Beconex Zi Syrup, Cabolin Tablet, Flontin Tablet, Ivana Tablet, and others. Some of the animal health products offered by the company are Doxivet Powder, Fevenil Injection, Diadin Bolus, Renamet Tablet, and others. The company operates in Bangladesh and sells its products locally and internationally.
83GF Score

Get the complete analysis for DHA:RENATA

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT446.30
Price
BDT806.73
GF Value